Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Deferred Taxes came in at $30.0 million in Q1 2026, up 433.33% year-on-year from $5.6 million in Q1 2025, and down 80.65% quarter-over-quarter from $155.0 million in Q4 2025.
Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Deferred Taxes across 18 years of filings, most recently posting $30.0 million for Q1 2026.
- Deferred Taxes for Q1 2026 came in at $30.0 million, up 433.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.0 million (up 4.39% YoY), and the FY2025 annual result was $80.0 million, up 21.21% from the prior year.
- Deferred Taxes came in at $30.0 million for Q1 2026 at Bausch Health Companies, down from $155.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $170.0 million in Q4 2024 to a low of -$96.0 million in Q3 2022.
- The 5-year median for Deferred Taxes is -$12.5 million (2022), against an average of $3.2 million.
- Across the five-year window, Deferred Taxes sank 700.0% in 2025 and soared 433.33% in 2026, its largest moves.
- Bausch Health Companies' Deferred Taxes stood at $19.0 million in 2022, then soared by 342.11% to $84.0 million in 2023, then soared by 102.38% to $170.0 million in 2024, then dropped by 8.82% to $155.0 million in 2025, then slumped by 80.65% to $30.0 million in 2026.
- The last three Deferred Taxes figures came in at $30.0 million (Q1 2026), $155.0 million (Q4 2025), and -$24.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -13.98 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 19.33 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 30.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.00 Mn |
| Dec 31, 2025 | 155.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Mar 31, 2025 | -9.00 Mn |
| Dec 31, 2024 | 170.00 Mn |
| Sep 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -44.00 Mn |
| Mar 31, 2024 | -57.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -30.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | -96.00 Mn |
| Jun 30, 2022 | -16.00 Mn |
| Mar 31, 2022 | -83.00 Mn |
| Dec 31, 2021 | -88.00 Mn |
| Sep 30, 2021 | -17.00 Mn |
| Jun 30, 2021 | -106.00 Mn |
| Mar 31, 2021 | -14.00 Mn |